 | • レポートコード：QYR9ST07323 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、腫瘍学小分子薬の世界市場について調査・分析し、腫瘍学小分子薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他）、用途別（血液癌、乳癌、胃腸癌、前立腺癌、肺癌、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍学小分子薬市場動向 ・主要企業別マーケットシェア ・腫瘍学小分子薬の種類別市場規模2014-2019 （化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他） ・腫瘍学小分子薬の用途別市場規模2014-2019 （血液癌、乳癌、胃腸癌、前立腺癌、肺癌、その他） ・腫瘍学小分子薬の北米市場：主要企業・種類別/用途別市場規模 ・腫瘍学小分子薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腫瘍学小分子薬の中国市場：主要企業・種類別/用途別市場規模 ・腫瘍学小分子薬の日本国内市場：主要企業・種類別/用途別市場規模 ・腫瘍学小分子薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・腫瘍学小分子薬のインド市場：主要企業・種類別/用途別市場規模 ・腫瘍学小分子薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche、Novartis、Pfizer、Celgene、Bristol-Myers Squibb、Amgen、Johnson & Johnson、AbbVie、Sanofi、Takeda、Eli Lilly、Bayer、AstraZeneca、Astellas、Merck、Biogen Idec、Eisai、Teva、Otsuka、Ipsen、Gilead Sciences、Exelixis） ・腫瘍学小分子薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths.In 2018, the global Oncology Small Molecule Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oncology Small Molecule Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Small Molecule Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Market segment by Type, the product can be split into
Chemotherapy Drugs
Immunomodulating Drugs
Targeted Therapy Drugs
Hormonal Therapy
Other
Market segment by Application, split into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncology Small Molecule Drugs status, future forecast, growth opportunity, key market and key players.
To present the Oncology Small Molecule Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncology Small Molecule Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy Drugs
1.4.3 Immunomodulating Drugs
1.4.4 Targeted Therapy Drugs
1.4.5 Hormonal Therapy
1.4.6 Other
1.5 Market by Application
1.5.1 Global Oncology Small Molecule Drugs Market Share by Application (2019-2025)
1.5.2 Blood Cancer
1.5.3 Breast Cancer
1.5.4 Gastrointestinal Cancer
1.5.5 Prostate Cancer
1.5.6 Lung Cancer
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oncology Small Molecule Drugs Market Size
2.2 Oncology Small Molecule Drugs Growth Trends by Regions
2.2.1 Oncology Small Molecule Drugs Market Size by Regions (2019-2025)
2.2.2 Oncology Small Molecule Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Oncology Small Molecule Drugs Market Size by by Players
3.1.1 Global Oncology Small Molecule Drugs Revenue by by Players (2014-2019)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Oncology Small Molecule Drugs Key Players Head office and Area Served
3.3 Key Players Oncology Small Molecule Drugs Product/Solution/Service
3.4 Date of Enter into Oncology Small Molecule Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oncology Small Molecule Drugs Market Size by Type (2014-2019)
4.2 Global Oncology Small Molecule Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Oncology Small Molecule Drugs Market Size (2014-2019)
5.2 Oncology Small Molecule Drugs Key Players in North America
5.3 North America Oncology Small Molecule Drugs Market Size by Type
5.4 North America Oncology Small Molecule Drugs Market Size by Application
6 Europe
6.1 Europe Oncology Small Molecule Drugs Market Size (2014-2019)
6.2 Oncology Small Molecule Drugs Key Players in Europe
6.3 Europe Oncology Small Molecule Drugs Market Size by Type
6.4 Europe Oncology Small Molecule Drugs Market Size by Application
7 China
7.1 China Oncology Small Molecule Drugs Market Size (2014-2019)
7.2 Oncology Small Molecule Drugs Key Players in China
7.3 China Oncology Small Molecule Drugs Market Size by Type
7.4 China Oncology Small Molecule Drugs Market Size by Application
8 Japan
8.1 Japan Oncology Small Molecule Drugs Market Size (2014-2019)
8.2 Oncology Small Molecule Drugs Key Players in Japan
8.3 Japan Oncology Small Molecule Drugs Market Size by Type
8.4 Japan Oncology Small Molecule Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oncology Small Molecule Drugs Market Size (2014-2019)
9.2 Oncology Small Molecule Drugs Key Players in Southeast Asia
9.3 Southeast Asia Oncology Small Molecule Drugs Market Size by Type
9.4 Southeast Asia Oncology Small Molecule Drugs Market Size by Application
10 India
10.1 India Oncology Small Molecule Drugs Market Size (2014-2019)
10.2 Oncology Small Molecule Drugs Key Players in India
10.3 India Oncology Small Molecule Drugs Market Size by Type
10.4 India Oncology Small Molecule Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Oncology Small Molecule Drugs Market Size (2014-2019)
11.2 Oncology Small Molecule Drugs Key Players in Central & South America
11.3 Central & South America Oncology Small Molecule Drugs Market Size by Type
11.4 Central & South America Oncology Small Molecule Drugs Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oncology Small Molecule Drugs Introduction
12.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2014-2019))
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oncology Small Molecule Drugs Introduction
12.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oncology Small Molecule Drugs Introduction
12.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Celgene
12.4.1 Celgene Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oncology Small Molecule Drugs Introduction
12.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.4.5 Celgene Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oncology Small Molecule Drugs Introduction
12.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oncology Small Molecule Drugs Introduction
12.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oncology Small Molecule Drugs Introduction
12.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 AbbVie
12.8.1 AbbVie Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oncology Small Molecule Drugs Introduction
12.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.8.5 AbbVie Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oncology Small Molecule Drugs Introduction
12.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.9.5 Sanofi Recent Development
12.10 Takeda
12.10.1 Takeda Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oncology Small Molecule Drugs Introduction
12.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2014-2019)
12.10.5 Takeda Recent Development
12.11 Eli Lilly
12.12 Bayer
12.13 AstraZeneca
12.14 Astellas
12.15 Merck
12.16 Biogen Idec
12.17 Eisai
12.18 Teva
12.19 Otsuka
12.20 Ipsen
12.21 Gilead Sciences
12.22 Exelixis
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Oncology Small Molecule Drugs Key Market Segments
Table Key Players Oncology Small Molecule Drugs Covered
Table Global Oncology Small Molecule Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Chemotherapy Drugs Figures
Table Key Players of Chemotherapy Drugs
Figuer Immunomodulating Drugs Figures
Table Key Players of Immunomodulating Drugs
Figuer Targeted Therapy Drugs Figures
Table Key Players of Targeted Therapy Drugs
Figuer Hormonal Therapy Figures
Table Key Players of Hormonal Therapy
Figuer Other Figures
Table Key Players of Other
Table Global Oncology Small Molecule Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Oncology Small Molecule Drugs Market Share by Application in 2018 & 2025
Figure Blood Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Gastrointestinal Cancer Case Studies
Figure Prostate Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Other Case Studies
Figure Oncology Small Molecule Drugs Report Years Considered
Figure Global Oncology Small Molecule Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oncology Small Molecule Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Oncology Small Molecule Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Oncology Small Molecule Drugs Market Share by Regions 2014-2019
Figure Global Oncology Small Molecule Drugs Market Share by Regions 2014-2019
Figure Global Oncology Small Molecule Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Oncology Small Molecule Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Oncology Small Molecule Drugs Market Share by by Players (2014-2019)
Figure Global Oncology Small Molecule Drugs Market Share by by Players in 2018
Table Global Oncology Small Molecule Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oncology Small Molecule Drugs Product/Solution/Service
Table Date of Enter into Oncology Small Molecule Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Small Molecule Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Oncology Small Molecule Drugs Market Size Share by Type (2014-2019)
Figure Global Oncology Small Molecule Drugs Market Size Market Share by Type (2014-2019)
Table Global Oncology Small Molecule Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Oncology Small Molecule Drugs Market Size Share by Application (2014-2019)
Figure Global Oncology Small Molecule Drugs Market Size Market Share by Application (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Market Share by Application in 2018
Figure North America Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table North America Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table North America Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Oncology Small Molecule Drugs Market Share by Application 2014-2019
Figure Europe Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table Europe Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table Europe Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Oncology Small Molecule Drugs Market Share by Application 2014-2019
Figure China Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table China Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table China Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table China Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table China Oncology Small Molecule Drugs Market Share by Application 2014-2019
Figure Japan Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table Japan Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table Japan Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Oncology Small Molecule Drugs Market Share by Application 2014-2019
Figure Southeast Asia Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table Southeast Asia Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table Southeast Asia Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Oncology Small Molecule Drugs Market Share by Application 2014-2019
Figure India Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table India Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table India Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table India Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table India Oncology Small Molecule Drugs Market Share by Application 2014-2019
Figure Central & South America Oncology Small Molecule Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oncology Small Molecule Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oncology Small Molecule Drugs Market Share (2018-2019)
Table Central & South America Oncology Small Molecule Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Oncology Small Molecule Drugs Market Share by Type 2014-2019
Table Central & South America Oncology Small Molecule Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Oncology Small Molecule Drugs Market Share by Application 2014-2019
Table Roche Company Details
Table Roche Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Celgene Company Details
Table Celgene Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Celgene Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Amgen Company Details
Table Amgen Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Amgen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Takeda Company Details
Table Takeda Revenue in Oncology Small Molecule Drugs Business 2014-2019 (Million US$)
Figure Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2014-2019)
Table Takeda Recent Development
Table Eli Lilly Company Details
Table Bayer Company Details
Table AstraZeneca Company Details
Table Astellas Company Details
Table Merck Company Details
Table Biogen Idec Company Details
Table Eisai Company Details
Table Teva Company Details
Table Otsuka Company Details
Table Ipsen Company Details
Table Gilead Sciences Company Details
Table Exelixis Company Details
Table Global Oncology Small Molecule Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Oncology Small Molecule Drugs Market Size Share by Regions (2019-2025)
Figure Global Oncology Small Molecule Drugs Market Size Share by Regions in 2025
Figure North America Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oncology Small Molecule Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Oncology Small Molecule Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Oncology Small Molecule Drugs Market Size by Product (2019-2025)
Figure Global Oncology Small Molecule Drugs Market Size by Product in 2025
Table Global Oncology Small Molecule Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Oncology Small Molecule Drugs Market Size by Application (2019-2025)
Figure Global Oncology Small Molecule Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がん支持療法薬の世界市場：市場規模・現状・予測 Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy.Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored…- 世界のオンコロジージェネリック注射薬市場：専門的調査 Generic drugs are essential in oncology because some anticancer drugs are only available as generics. The global Oncology Generic Injectable Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focu…
- 胃腸癌治療薬の世界市場：インサイト・予測 Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …